Connection
Cecilia Low Wang to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Cecilia Low Wang has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.795 |
|
|
|
-
McRae M, Low Wang CC. Macrovascular Complications. Prim Care. 2022 Jun; 49(2):255-273.
Score: 0.656
-
Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016 Jun 14; 133(24):2459-502.
Score: 0.109
-
Hess CN, Low Wang CC, Hiatt WR. PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes. Annu Rev Med. 2018 01 29; 69:133-145.
Score: 0.030